ID Genomics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

ID Genomics General Information

Description

Developer of genomics bar-coding-based diagnostic system designed to help match infecting bugs with the correct drug. The company's system combines molecular diagnostics with epidemiological surveillance and big-data tools to guide antibiotic choices within a short span of time, before the patient leaves the doctor's office or clinic, enabling healthcare providers to offer personalized treatment for infectious diseases thereby improving the lives of patients.

Contact Information

Website
www.idgenomics.com
Formerly Known As
ID Genomics, Inc., Idgenomics Inc.
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 13751 Lake City Way North East
  • Suite 350
  • Seattle, WA 98125
  • United States
+1 (425)
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Big Data, Digital Health, TMT, HealthTech, Life Sciences
Corporate Office
  • 13751 Lake City Way North East
  • Suite 350
  • Seattle, WA 98125
  • United States
+1 (425)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ID Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 26-May-2022 Completed Out of Business
7. Grant 26-Aug-2021 Completed Generating Revenue
6. Grant 05-Aug-2021 Completed Generating Revenue
5. Later Stage VC 01-Apr-2019 Completed Generating Revenue
4. Later Stage VC (Series A2) 18-Dec-2018 Completed Generating Revenue
3. Later Stage VC (Series A1) 07-Mar-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 07-Apr-2017 $676K $676K Completed Generating Revenue
1. Grant 02-May-2016 $3M Completed Generating Revenue
To view ID Genomics’s complete valuation and funding history, request access »

ID Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
Series A 500,000 $0.001000 $2 $2 1x $2 10%
To view ID Genomics’s complete cap table history, request access »

ID Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genomics bar-coding-based diagnostic system designed to help match infecting bugs with the correct drug. Th
Biotechnology
Seattle, WA
3 As of 2021

New York, NY
 

Stamford, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ID Genomics Competitors (2)

One of ID Genomics’s 2 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY
Loxo Oncology Formerly VC-backed Stamford, CT
You’re viewing 2 of 2 competitors. Get the full list »

ID Genomics Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

ID Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210214758-A1 Methods and tools for determining clonal relatedness and predicting clonal traits Inactive 07-May-2018
CA-3099424-A1 Methods and tools for determining clonal relatedness and predicting clonal traits Inactive 07-May-2018
EP-3790981-A1 Methods and tools for determining clonal relatedness and predicting clonal traits Inactive 07-May-2018
EP-3790981-A4 Methods and tools for determining clonal relatedness and predicting clonal traits Inactive 07-May-2018
EP-3262198-A1 Process and kit for predicting antibiotic resistance and susceptibility of bacteria Inactive 26-Feb-2015 C12Q1/689
To view ID Genomics’s complete patent history, request access »

ID Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ID Genomics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
UW CoMotion Accelerator/Incubator
To view ID Genomics’s complete investors history, request access »

Ready to get started?

Request a free trial

ID Genomics FAQs

  • When was ID Genomics founded?

    ID Genomics was founded in 2012.

  • Where is ID Genomics headquartered?

    ID Genomics is headquartered in Seattle, WA.

  • What is the size of ID Genomics?

    ID Genomics has 3 total employees.

  • What industry is ID Genomics in?

    ID Genomics’s primary industry is Biotechnology.

  • Is ID Genomics a private or public company?

    ID Genomics is a Private company.

  • What is ID Genomics’s current revenue?

    The current revenue for ID Genomics is .

  • How much funding has ID Genomics raised over time?

    ID Genomics has raised $2.84M.

  • Who are ID Genomics’s investors?

    UW CoMotion has invested in ID Genomics.

  • Who are ID Genomics’s competitors?

    Volastra and Loxo Oncology are competitors of ID Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »